Drugs / sulpegfilgrastim
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07018271 | Jun 2025 → Jun 2026 overdue | neutropenia, plasma cell myeloma | The First Affiliated Hospital of Soochow University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulpegfilgrastim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07018271 ↗ |
| Modality | Protein / enzyme biologic | “a pegylated recombinant human granulocyte colony-stimulating factor” NCT07018271 ↗ |